EN
HI
Brooks Laboratories share price chart
Brooks Laboratories Share Key Metrics
Volume
18992.00
Market Cap
176.74 CR
LTQ@LTP
9@60.00
ATP
59.81
Var Margin
100 %
Circuit Range
57-63
Delivery %
0 %
Value
11.36 L
ASM/GSM
No
Market Lot
1
Summary
BROOKS stock price is ₹60 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹59.00 and ₹60.99, while Brooks Laboratories share price 52 week high low is ₹36.30 & ₹163.90.
In terms of trading activity, BROOKS share price has recorded a volume of 18,992 shares. The Brooks Laboratories has a market cap of ₹29457248. The stock’s Average Traded Price (ATP) stands at ₹59.81, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹60.00.
The Brooks Laboratories upper circuit limit is ₹63.00 & The Brooks Laboratories lower circuit limit is ₹57.00, with a Value of ₹11.36 L. The Delivery Percentage for the day is 0%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Brooks Laboratories Fundamentals
P/E Ratio
13.24
P/B Ratio
1.41
Div. Yield
0
Sector P/E
69.06
Sector P/B
3.36
Sec. Div. Yield
0.51
Brooks Laboratories Resistance and Support
Pivot 60.25
Resistance
First Resistance
61.25
Second Resistance
62.2
Third Resistance
63.2
Support
First Support
59.3
Second Support
58.3
Third Support
57.35
Brooks Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 59.1 | 60 | -0.48% | 60.99 | 59 |
| Thu Aug 20 2026 | 61.2 | 60.29 | 2.05% | 61.2 | 59.25 |
| Wed Aug 19 2026 | 60 | 59.08 | 0.25% | 61 | 58.75 |
Brooks Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-29 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2024-12-11 | To consider Fund Raising & Others |
| 2024-11-09 | Quarterly Results |
Brooks Laboratories News
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026
Brooks Laboratories approved its Q1 FY27 results, reporting a standalone net profit of ₹1.42 crores. The company posted a consolidated net loss of ₹1.79 crores, a significant reversal from the previous year's profit, largely due to a ₹3.21 crore loss from its jointly controlled entity, Brooks Steriscience Limited.
Aug 13 2026 19:50:11
Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (''''SEBI Listing Regulations'''')
Brooks Laboratories' board is scheduled to meet on August 13, 2026. The primary agenda is to consider and approve the company's unaudited standalone and consolidated financial results for the first quarter of FY27.
Aug 06 2026 19:10:18
Brooks Laboratories Management
| Name | Position |
|---|---|
| Krutika Mohan Rane | Company Secretary & Compliance Officer |
| Bhushan Singh Rana | Whole Time Director |
Brooks Laboratories FAQs
The Buying Price of Brooks Laboratories share is 60 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brooks Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brooks Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brooks Laboratories shares is 13.24. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brooks Laboratories shares is 1.41. Useful to assess the stock's value relative to its book value.
To assess Brooks Laboratories’s valuation compare Sector P/E, P/B which are 69.06 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brooks Laboratories is 176.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brooks Laboratories share price is 163.90 & 36.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brooks Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
